This clinical trial examined the impact of repeated edetate disodium infusions on urinary excretion levels of lead and cadmium in individuals with a history of myocardial infarction. The findings suggest that chelation therapy effectively reduced lead levels, which may help lower cardiovascular risks associated with lead toxicity, but did not
